Inducer of Functional Neurorestoration Via the Sigma-1 Receptor

Novel inhibitor of checkpoint kinase 1 (CHK1)

Inverse agonist at alpha-1 adrenergic receptors

Inhibitor of prostaglandin (PG) synthesis

Quorum sensing modulator as a PqsR antagonist

Novel human double minute 2 (HDM2) inhibitor

Novel inhibitor of IMPDH enzyme

Novel potent neuroprotectant, inhibiting glutamate-induced cell death, caspase-3 activation, and amyloid β1-42-induced cell death, also suppressing mitogen-activated protein kinase kinase 4 (MKK4) and c-jun N-terminal kinase (JNK) signaling activated by n

Specific blocker of the MARV VP40 PPxY-host Nedd4 interaction and subsequent PPxY-dependent egress of MARV VP40 VLPs.

Novel inhibitor of budding of mVP40 and eVP40 VLPs, blocking mVP40-795 Nedd4 protein-protein interaction.

Novel Modulator of Water-Heme Interactions in Low-Spin P450 Complexes of CYP2C9d and CYP125A1

Novel anti-influenza agent, interrupting the crucial RNP trafficking, resulting in influenza replication inhibition, preventing virus-induced cytopathic effects

Potent and selective antagonist of melanocortin-4 receptor (MC4R)

Novel PPK1 inhibitor, preventing UTI effectively through the disruption of the PPK1 function

Novel PPK1 inhibitor, preventing UTI effectively through the disruption of the PPK1 function

Novel pan-RAS-effector PPI inhibitor

Novel insulin mimetic

Novel inhibitor of protein-protein interaction (PPI), blocking #212121; font-family: BlinkMacSystemFont, -apple-system, "Segoe UI", Roboto, Oxygen, Ubuntu, Cantarell, "Fira Sans", "Droid Sans", "Helvetica Neue", sans-serif; font-size: 14px; font-style: no

Novel dual PPARα/γ agonist, ameliorating insulin resistance and gluconeogenesis in vivo and vitro

The first reported PPARα/δ dual antagonist

Novel iNOS homodimerization inhibitor

Novel pan-human EGF receptor (HER) inhibitor

Hypobetalipoproteinemic and Lipid decreasing agent

Potent Activator of Vγ9Vδ2 T-Lymphocytes; HMBPP ananlog prodrug

Novel pan-inhibitor of KCa3.1/KCa2 channels

Antibiotic as a last-line therapy to treat infections caused by these life-threatening 'superbugs'

Novel activator of Adenosine monophosphate (AMP)-activated protein kinase (AMPK)

Used for the transfection of a broad variety of cell lines; Antimicrobial; Novel binding agent of diffusive gradients in thin-films (DGT) technique (PEI-DGT)

Pan-Specific Inhibitor of the Polo-Box Domains of Polo-like Kinases Arrests Cancer Cells in Mitosis

Novel modulator of protein-protein interactions of the mitotic polo-like kinases, targeting KRAS mutant xenografts, indicate avenues, acting synergistically with Crizotinib, an inhibitor of the c-MET receptor, against mutant KRAS-expressing cancer cells